Rocket Pharmaceuticals is trading at $3.25 (-7.02%) in after-hours trading following a regular session close of $3.50, with no verified company-specific news or earnings announcements found to explain the move.
- The decline likely reflects thin after-hours liquidity rather than fundamental developments or late-breaking corporate disclosures.
- Broader market sentiment may be a contributing factor, as the Nasdaq also finished the regular session in negative territory.